# Quantitative susceptibility mapping of the cervical spinal cord for MS monitoring

Benjamin Streichenberger, Mathieu Santin, Stéphane Roche, Guillemot

Catherine, Benoit Combès, Anne Kerbrat, Elise Bannier

► To cite this version:

Benjamin Streichenberger, Mathieu Santin, Stéphane Roche, Guillemot Catherine, Benoit Combès, et al.. Quantitative susceptibility mapping of the cervical spinal cord for MS monitoring. SFRMBM 2025 - 7ème congrès de la Société Française de Résonance Magnétique en Biologie et Médecine, Mar 2025, Saint Malo, France. hal-05457572

HAL Id: hal-05457572

https://hal.science/hal-05457572v1

Submitted on 14 Jan 2026

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
# QUANTITATIVE SUSCEPTIBILITY MAPPING OF THE CERVICAL SPINAL CORD FOR MULTIPLE SCLEROSIS MONITORING

Benjamin Streichenberger¹, Mathieu Santin⁴, Stéphane Roche³, Catherine Guillemot⁴, Benoit Combès¹, Anne Kerbrat¹,⁵, Élise Bannier¹,⁴

¹ INRIA, EMPENN, Rennes, France, ²Paris Brain Institute-ICM, Centre de Neurolmagerie de Recherche (CENIR), Paris, France, ³Ventio, Marseille, France, ⁴CHU, Radiology Department, Rennes, France, ⁵CHU, Neurology Department, Rennes, France

**Objectives:** Quantitative susceptibility mapping (QSM) [1] is a promising MRI technique that can be used in multiple sclerosis (MS) to characterize lesions and serve as a biomarker of chronic inflammation in white matter lesions. While QSM has been widely used for brain applications, its feasibility in the spinal cord (SC) has not been demonstrated. Yet, SC lesions are seen in up to 80% of people with MS and have a strong prognostic value. Moreover, a histopathologic study [2] found a high prevalence of 41% chronic active SC lesions among lesions of 119 MS patients. Thus, a QSM tool capable of quantifying the inflammatory status of SC lesions could be of great value in better understanding MS and tailoring treatments.

**Materials and Methods:** The presence of fat in the spinal cord prompted us to use a water-fat separation IDEAL technique [3] (implemented in python) to estimate the total field before computing the QSM map using the algorithm MEDI [1] (available in the open-source software Sepia [4]). For initialization of IDEAL, we designed a 2-sequence MRI protocol that provides in-phase (IP) and out-of-phase (OOP) SC QSM data. Images from 8 healthy controls (HC) and 5 MS patients were acquired on a 3T Prisma scanner (clinical trials ID: NCT05622643; NCT05107232) in the axial plane between C3 and C5 with high spatial resolution (0.4x0.4x1mm³, TE1 IP 2.64ms, TE1 OOP 3.69ms, ΔTE=2.46ms, TR 33ms, 12 echoes each).

**Results:** We obtain encouraging SC QSM maps where it is possible to distinguish hyperintense gray matter and QSM signal variations in lesions, as shown below in a HC (fig. 1) and an MS patient (fig2.). The T2* axial patient image was used to segment lesions (in green on QSM).

<figure><img src="image_2.png" /><figcaption>Fig 1: HC T2* axial (left) and QSM (right) [-0.05;0.05 ppm]</figcaption></figure>

<figure><img src="image_3.png" /><figcaption>Fig 2: MS patient T2* axial (left) and QSM (right) [-0.05;0.05 ppm]</figcaption></figure>

**Conclusion:** We showed that SC QSM with high spatial resolution is feasible and allows to detect QSM signal variations in lesions. Future prospects include increasing the number of patients, classifying SC lesions according to QSM maps, and a reproducibility study.

**References:** [1] Wang Y et al. MRM 2015; [2] Waldman A, et al. Acta Neuropathol 2024; [3] Guo et al. NMR Biomed 2019; [4] Chan et al. Neuroimage, 2021.

**Acknowledgments:** This work is supported by the RHU PRIMUS, FLI RE4 QSM-SPICO and France SEP.